West Pharmaceutical Shuttering Montgomery, Pennsylvania, Plant
12/07/2010
"The changing landscapes in the healthcare and consumer markets we serve require that we regularly evaluate our operations and adapt to changing conditions in order to successfully compete," said Donald E. Morel Jr., West's chairman and CEO. "The plans announced today will reduce the manufacturing capacity devoted to product lines that no longer support sustainable, competitive operations. These are difficult decisions that fall most heavily on our employees in these locations, and we will be providing support that should ease the burden placed on them."
The facility produced molded plastic components and assemblies for consumer products.
Project Announcements
United Kingdom-Based Risk Ledger Plans Rockville, Maryland, Operations
04/03/2026
Umbra Plans Reston, Virginia, Engineering-Production Operations
04/03/2026
Associated Wholesale Grocers Expands Pearl River, Louisiana, Distribution Operations
04/02/2026
Brazil-Based TSEA Energy Plans Eden, North Carolina, Manufacturing Operations
04/02/2026
AMAROK Plans Columbia, South Carolina, Headquarters Operations
04/02/2026
Belgium-Based UCB Plans Gwinnett County, Georgia, Manufacturing Operations
04/01/2026
Most Read
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Economic Developer Role Shifting from Deal-Making to Systems Stewardship
Q1 2026
-
What Companies Need from Modern Manufacturing Sites
Q1 2026
-
Capitalizing on the OBBBA Before the 2026 Cliff
Q1 2026
-
Last Word: Don’t Lose by Winning
Q1 2026
-
Advanced Manufacturing Isn’t a Buzzword—It’s a Different Location Strategy
Q1 2026
-
The Geography of Packaging: Why Location Strategy Matters More Than Ever
Q1 2026